{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T20:28:46Z","timestamp":1740169726647,"version":"3.37.3"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":326,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006084","name":"National Institutes of Health Office of AIDS Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006084","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research Reports"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.lrr.2024.100489","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T21:10:48Z","timestamp":1732309848000},"page":"100489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Indolent infections in patients with hematologic malignancy: A single-center experience screening for tuberculosis and strongyloidiasis prior to cytotoxic therapy in Boston"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2580-0675","authenticated-orcid":false,"given":"K.A.","family":"Reifler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8323-1300","authenticated-orcid":false,"given":"T.","family":"Francoeur Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Bodanapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Fagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.L.","family":"Bourque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lrr.2024.100489_bib0001","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1164\/rccm.201508-1683OC","article-title":"The prevalence of latent tuberculosis infection in the United States","volume":"194","author":"Mancuso","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.lrr.2024.100489_bib0002","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9060468","article-title":"The global prevalence of strongyloides stercoralis infection","volume":"9","author":"Buonfrate","year":"2020","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.lrr.2024.100489_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/cmr.00033-23","article-title":"Human strongyloidiasis: complexities and pathways forward","volume":"36","author":"Buonfrate","year":"2023","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.lrr.2024.100489_bib0004","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/S2214-109X(18)30490-X","article-title":"Prevalence of strongyloidiasis and schistosomiasis among migrants: a systematic review and meta-analysis","volume":"7","author":"Asundi","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.lrr.2024.100489_bib0005","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijid.2020.09.002","article-title":"Modeling strongyloidiasis risk in the United States","volume":"100","author":"Singer","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.lrr.2024.100489_bib0006","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/cid\/ciw838","article-title":"Risk of active tuberculosis in patients with cancer: a systematic review and metaanalysis","volume":"64","author":"Cheng","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.lrr.2024.100489_bib0007","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s15010-015-0799-1","article-title":"Strongyloides stercoralis hyperinfection syndrome: a case series and a review of the literature","volume":"43","author":"Geri","year":"2015","journal-title":"Infection"},{"issue":"9","key":"10.1016\/j.lrr.2024.100489_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022445","article-title":"Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines","volume":"8","author":"Hasan","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.lrr.2024.100489_bib0009","unstructured":"National Comprehensive Cancer Network. Prevention and treatment of cancer related infections. Published January 2024. Accessed June 20, 2024. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/infections.pdf."},{"issue":"2","key":"10.1016\/j.lrr.2024.100489_bib0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cid\/ciw778","article-title":"Official American Thoracic Society\/Infectious Diseases Society of America\/Centers for Disease Control and Prevention clinical practice guidelines: diagnosis of tuberculosis in adults and children","volume":"64","author":"Lewinsohn","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.lrr.2024.100489_bib0011","doi-asserted-by":"crossref","first-page":"645","DOI":"10.4269\/ajtmh.16-0923","article-title":"Evidence-based guidelines for screening and management of strongyloidiasis in non-endemic countries","volume":"97","author":"Requena-M\u00e9ndez","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"7","key":"10.1016\/j.lrr.2024.100489_bib0012","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz172","article-title":"Seroprevalence of Strongyloides stercoralis and evaluation of universal screening in kidney transplant candidates: a single-center experience in Houston (2012-2017)","volume":"6","author":"Al-Obaidi","year":"2019","journal-title":"Open. Forum. Infect. Dis."},{"key":"10.1016\/j.lrr.2024.100489_bib0013","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.mm7112a1","article-title":"Tuberculosis \u2014 United States, 2021","volume":"71","author":"Filardo","year":"2022","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"year":"2023","series-title":"Global Tuberculosis Report 2023","key":"10.1016\/j.lrr.2024.100489_bib0014"},{"issue":"12","key":"10.1016\/j.lrr.2024.100489_bib0015","doi-asserted-by":"crossref","first-page":"9325","DOI":"10.3390\/curroncol29120731","article-title":"Implementation of a routine screening program for latent tuberculosis infection among patients with acute leukemia at a Canadian cancer center","volume":"29","author":"Taha","year":"2022","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.lrr.2024.100489_bib0016","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2024.054","article-title":"Acute leukemia and latent tuberculosis infection in Italy: quantiferon-Tb test screening in a low tuberculosis incidence country","volume":"16","author":"Nunzi","year":"2024","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"5","key":"10.1016\/j.lrr.2024.100489_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-002321","article-title":"Cost-effectiveness of different strategies for screening and treatment of Strongyloides stercoralis in migrants from endemic countries to the European Union","volume":"5","author":"Wikman-Jorgensen","year":"2020","journal-title":"BMJ Glob. Health"}],"container-title":["Leukemia Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048924000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213048924000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T20:38:02Z","timestamp":1733431082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213048924000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":17,"alternative-id":["S2213048924000797"],"URL":"https:\/\/doi.org\/10.1016\/j.lrr.2024.100489","relation":{},"ISSN":["2213-0489"],"issn-type":[{"type":"print","value":"2213-0489"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indolent infections in patients with hematologic malignancy: A single-center experience screening for tuberculosis and strongyloidiasis prior to cytotoxic therapy in Boston","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lrr.2024.100489","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100489"}}